Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stanislav S. Kamyshanov
Observed names:
S. S. Kamyshanov,
Stanislav Kamyshanov
Institution:
Pirogov Russian National Research Medical University
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0009-0007-1455-5137
Observed ORCID:
0009-0007-1455-5137
OpenAlex ID:
A5092560042
First experience with Isatuximab in newly diagnosed multiple myeloma patients. Case report
2026
·
Anastasiya A. Semenova
, Nikita O. Zemlyakov
, et al.
·
Journal of Modern Oncology
PDF
Experience with prolgolimab in the treatment of patients with relapsed and refractory classical Hodgkin lymphoma
2025
·
Valeria Shpirko
, Anastasia Semenova
, et al.
·
Blood
PET/CT parameters as predictors of early progression risk in newly diagnosed multiple myeloma patients eligible for autologous stem cell transplantation
2025
·
Stanislav Kamyshanov
, Anastasia Semenova
, et al.
·
Blood
PDF
Dara-RVD in newly diagnosed multiple myeloma: Real-world clinical practice
2025
·
Anastasia Semenova
, Stanislav Kamyshanov
, et al.
·
Blood
Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia
2025
·
Anastasiya Aleksandrovna Semenova
, A. S. Luchinin
, et al.
·
Clinical oncohematology
PDF
COVID-19: аn Update on the Modern Etiotropic Therapy Methods for the New Coronavirus Infection
2023
·
Evgeny A. Sinitsyn
, Ekaterina V. Smolyakova
, et al.
·
Journal of clinical practice
PDF
Show more works
View as search
Works count:
6
Citation count:
H-index:
I10-index:
Year
Topic
Type